ENAVATE SCIENCES GP, LLC: BRVE position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ENAVATE SCIENCES GP, LLC on BRVE, newest first. How the timeline and the estimate are built.
ENAVATE SCIENCES GP, LLC held 3,674,656 BRVE shares at 2026-09-30 per its 13F-HR filed 2026-11-16.
the latest 13F is the newest step
- period ended2026-09-3013F 3,674,656 sharesChange vs previous 13F not available
26.53% of the 13F portfolio, value $74,228,051.
13F-HR 0001953107-26-000019 filed by ENAVATE SCIENCES GP, LLC
Accepted , ingested